A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit.
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Antimicrobial de-escalation (ADE) is a strategy to reduce the spectrum of antimicrobials and aims to prevent the emergence of bacterial resistance. We present a systematic review describing the definitions, determinants and outcomes associated with ADE. We included 2 randomized controlled trials and 12 cohort studies. There was considerable variability in the definition of ADE. It was more frequently performed in patients with broad-spectrum and/or appropriate antimicrobial therapy (P= .05 to .002), when more agents were used (P= .002), and in the absence of multidrug-resistant pathogens (P< .05). Where investigated, lower or improving severity scores were consistently associated with ADE (P= .04 to <.001). The pooled effect of ADE on mortality is protective (relative risk, 0.68; 95% confidence interval, .52-.88). Because the determinants of ADE are markers of clinical improvement and/or of lower risk of treatment failure this effect on mortality cannot be retained as evidence. None of the studies were designed to investigate the effect of ADE on antimicrobial resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most studies were observational, and there are concerns that de-escalation is used primarily in patients who are getting better, which is why the reported improved short-term mortality should be interpreted with caution [277, 279].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [279]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148 · cited 1×
“Interrater agreement was calculated with free marginal κ statistics [8].”
MethodMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“Heterogeneity among studies was evaluated using the χ(2) test based on the Cochran Q statistic and quantified by the I(2) value [9].”
MethodMeta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 4×
“by DerSimonian and Laird [10], with the Egger test used for publication bias.”
MethodInfluentialCochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
(2014) · Medical Entomology and Zoology · Cited by 17,633
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
SINGH, N., ROGERS, P., ATWOOD, C. W., WAGENER, M. M., & YU, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,032 · cited 1×
“has been studied for shortening treatment [27], to date there is no evidence of this for ADE because none of the published studies was designed to evaluate this variable.”
BackgroundGarnacho-Montero, J., Gutiérrez-Pizarraya, A., Escoresca-Ortega, A., Corcia-Palomo, Y., Fernández-Delgado, E., Herrera-Melero, I., Ortiz-Leyba, C., & Márquez-Vácaro, J. A. (2014) · Intensive Care Medicine · doi:10.1007/s00134-013-3077-7 · Cited by 389 · cited 12×
“GarnachoMontero et al [22] 2014 No specific antimicrobials described Yes Yes No Yes Not ranked Once culture results were available”
BackgroundMethodResultInfluentialSelf-citation
Research works printed but not linked: 1
- 5. Effective Practice and Organisation of Care (EPOC). EPOC resources for review authors. Oslo, Norway: Norwegian Knowledge Centre for the Health Services; 2014 . Available at: http://epoc.cochrane.org/epoc-speci fi c-resources-reviewauthors. Accessed 19 January 2016.
Cited by
Items 101–200 of 244
[Antimicrobial stewardship programme implementation in a medical ward].
Ruiz, J., Salavert, M., Ramírez, P., Montero, M., Castro, I., González, E. M., Romá, E., & Poveda, J. L. (2018) · PubMed Central · Cited by 14
Phantom Prescribing: Examining the Frequency of Antimicrobial Prescriptions Without a Patient Visit
Riedle, B. N., Polgreen, L. A., Cavanaugh, J. E., Schroeder, M. C., & Polgreen, P. M. (2016) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2016.269 · Cited by 13
zhao, K., Zhang, Z.-D., liang, Y., Wang, Y., & Cai, Y. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08491-7 · Cited by 13
“A lack of consensus among studies included in a previous meta-analysis on the definition of ADE further complicates the issue [23].”
BackgroundBohan, J. G., Remington, R. E., Jones, M., Samore, M. H., & Madaras‐Kelly, K. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw244 · Cited by 12
“Tabah et al [7] performed a systematic review studying de-escalation and patient outcomes in 2 randomized controlled trials and 12 cohort studies in ICU patients with pneumonia.”
BackgroundInfluentialvan Heijl, I., Schweitzer, V. A., van der Linden, P. D., Bonten, M. J. M., & van Werkhoven, C. H. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1743683 · Cited by 12
Sartelli, M., Cristini, F., Coccolini, F., Labricciosa, F. M., Siquini, W., & Catena, F. (2022) · Antibiotics · doi:10.3390/antibiotics11101394 · Cited by 12
“Antibiotic de-escalation is now considered a key point of antimicrobial stewardship programs in intensive care units (ICUs) [92].”
Backgroundvan Engelen, T. S. R., Wiersinga, W. J., & van der Poll, T. (2018) · Springer eBooks · doi:10.1007/978-3-319-73506-1_3 · Cited by 13
Optimal antibiotic use in the intensive care unit
Micek, S. T., Vazquez Guillamet, M. C., Reynolds, D., Matuszak, S., Kolodziej, L., & Kollef, M. H. (2025) · Critical Care · doi:10.1186/s13054-025-05653-8 · Cited by 11
“A systematic review of antibiotic de-escalation was able to identify factors associated with its successful implementation and demonstrated that the pooled effect of antibiotic de-escalation on mortality was protective (relative risk, 0.68; 95% confidence interval, 0.52-0.88) [76].”
InfluentialJha, N. K., Gopu, V., Sivasankar, C., Singh, S. R., Devi, P. B., Murali, A., & Shetty, P. H. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001813 · Cited by 11
Pérez-Torres, D., Tamayo-Lomas, L., González, M. D.-G., Almendros, R., Sacristán-Salgado, M. A., González-González, E., Berezo-García, J. Á., Díaz-Rodríguez, C., Canas-Pérez, I., Lorenzo-Vidal, B., et al. (2023) · Revista Española de Quimioterapia · doi:10.37201/req/142.2022 · Cited by 11
To which extent can we decrease antibiotic duration in critically ill patients?
Garnacho‐Montero, J., Arenzana, Á., Waele, J. J. D., & Kollef, M. H. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1369879 · Cited by 11
Self-citationEditorial Commentary: Antimicrobial De-escalation: What's in a Name?
Kollef, M. H., & Micek, S. T. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ1201 · Cited by 11
Antibiotic De-Escalation in Emergency General Surgery
Vallicelli, C., Minghetti, M., Sartelli, M., Coccolini, F., Ansaloni, L., Agnoletti, V., Bravi, F., & Catena, F. (2022) · Antibiotics · doi:10.3390/antibiotics11091148 · Cited by 10
“Tabah [5] Narrowing of the spectrum of antimicrobial treatment”
BackgroundMethodInfluentialA Critical Assessment of Time-to-Antibiotics Recommendations in Pediatric Sepsis
Chiotos, K., Balamuth, F., & Fitzgerald, J. C. (2024) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piae100 · Cited by 10
Bautista, A., de Vega-Ríos, E., Ballesteros, J. S., Brañas, D. U., Cardeñoso-Domingo, L., Tejerina, A. F., Teleki, A. V. W., Jiménez, D., Santos, I. D. L., & Béjar, C. S. (2022) · Revista Española de Quimioterapia · doi:10.37201/req/132.2021 · Cited by 11
Safety of antimicrobial de-escalation for culture-negative severe pneumonia
Soo, K. B., Choi, S., Koh, Y., Jin-Won, H., Sang-Bum, H., & Chae-Man, L. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.06.026 · Cited by 10
“The relationship between prolonged antimicrobial treatment and the emergence of MDR pathogens remains unclear [28].”
BackgroundSaliba, R., Mizrahi, A., de Ponfilly, G. P., Monnier, A. L., Zahar, J., & Pilmis, B. (2022) · Antibiotics · doi:10.3390/antibiotics11010070 · Cited by 10
Self-citationPilmis, B., Mizrahi, A., de Ponfilly, G. P., Philippart, F., Bruel, C., Zahar, J., & Monnier, A. L. (2021) · Journal of Hospital Infection · doi:10.1016/j.jhin.2021.03.022 · Cited by 8
Self-citationHuttner, B. D., Pulcini, C., & Schouten, J. A. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.09.024 · Cited by 8
Self-citationSaito, N., Tsuchiya, J., Itoga, M., Okamura, Y., Tsuyama, H., Kimura, M., Inoue, F., Kimura, T., Ozaki, H., Tono, Y., et al. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s445917 · Cited by 7
Safety considerations of current drug treatment strategies for nosocomial pneumonia
Ceccato, A., Giannatale, P. D., Nogas, S., & Torres, A. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1857362 · Cited by 7
Song, J., & Lee, J. H. (2023) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2023.115 · Cited by 7
Chambe, E., Bortolotti, P., Diesnis, R., Laurans, C., Héquette-Ruz, R., Panaget, S., Herbecq, P., Vachée, A., & Meybeck, A. (2023) · Antibiotics · doi:10.3390/antibiotics12121646 · Cited by 7
Wu, H., Mao, Y., Du, X., Zhao, F., Jiang, Y., & Yu, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.832655 · Cited by 7
“In clinical practice and previous studies, we observed that 2–3 days after initiation of the initial therapy is a recommended time point to evaluate the efficacy of the antibiotic therapy and do some adjustments if necessary in patients with BSI (15, 16).”
BackgroundBaghdadi, J. D., Goodman, K. E., Magder, L. S., Heil, E. L., Claeys, K. C., Bork, J. T., & Harris, A. D. (2023) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlad054 · Cited by 7
Corcione, S., Pinna, S. M., Lupia, T., Trentalange, A., Germanò, E., Cavallo, R., Lupia, E., & Rosa, F. G. D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153285 · Cited by 7
“This change also improved the quality of the microbiological work-up, the administration of appropriate antimicrobials, and compliance with the stewardship bundle by reducing the ICU admission rate [9].”
BackgroundRapti, V., Poulakou, G., Mousouli, A., Kakasis, A., Pagoni, S., Pechlivanidou, E., Masgala, A., Sympardi, S., Apostolopoulos, V., Giannopoulos, C., et al. (2024) · Antibiotics · doi:10.3390/antibiotics13090812 · Cited by 6
“ADE is a key component of ASP and refers to the discontinuation of one or more components of combination empirical therapy and/or the change from a broad-spectrum to a narrower spectrum antimicrobial [7,8].”
BackgroundInfluentialTu, M. M., Shi, Z. H., Leung, V., Brown, K. A., Schwartz, K. L., Daneman, N., & Langford, B. J. (2024) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2024.461 · Cited by 6
“23,24 Strengths of this study include a relatively large sample representing various hospital types from across the province.”
Farsani, A., Thandi, P., & Htway, Z. (2025) · Cureus · doi:10.7759/cureus.90728 · Cited by 6
“Therefore, antimicrobial stewardship programs emphasize timely de-escalation from broad-to-narrow spectrum agents (B2N) based on clinical and microbiological data [14,15].”
Yousuf, S., Rzewuska, M., Duncan, E., & Ramsay, C. R. (2022) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlac127 · Cited by 6
Antibiotic prescribing behavior among physicians in Asia: a multinational survey
Wiboonchutikula, C., Kim, H. B., Honda, H., Loo, A. Y. X., Cheng, V. C., Camins, B. C., Jantarathaneewat, K., Apisarnthanarak, P., Rutjanawech, S., & Apisarnthanarak, A. (2023) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2023.190 · Cited by 6
“24,30 Carbapenem de-escalation has been reported to be 45% – 50% by several studies.”
Backgroundde Lorenzi-Tognon, M., & Schrenzel, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-60041-6 · Cited by 6
Lakbar, I., Delamarre, L., Curtel, F., Duclos, G., Bézulier, K., Gragueb-Chatti, I., Martín‐Loeches, I., Forel, J.-M., & Léone, M. (2022) · Antibiotics · doi:10.3390/antibiotics11111517 · Cited by 6
“Previous studies have reported higher rates of ADE, but this can be also due to variations in the definition of ADE or the inclusion of less critically ill patients [18].”
BackgroundArora, G., Kumar, N., Singh, A., Ghosh, S., Chawla, A., Salhotra, R., Lyall, A., & Gupta, M. (2022) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24366 · Cited by 6
Widyasari, K., Lee, S. J., Cho, O., Hong, S.-I., Ryu, B.-H., & Kim, S. (2023) · Diagnostics · doi:10.3390/diagnostics13213335 · Cited by 6
Antimicrobial therapy in patients with septic shock
Pastène, B., Duclos, G., Martin, C., & Léone, M. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.03.006 · Cited by 7
“Reducing the spectrum and number of antibiotics as soon as the responsible pathogen is identified is, theoretically, an effective method to decrease the exposure of patients to antibiotics [38].”
BackgroundMethodAntimicrobial Stewardship in ICU
Schouten, J. A., & Waele, J. J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-810477-4.00016-7 · Cited by 6
Self-citationWoerther, P., Barbier, F., Lepeule, R., Fihman, V., & Ruppé, É. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1052 · Cited by 6
Scarpellini, R., Giunti, M., Bulgarelli, C., Esposito, E., Mondo, E., Tumietto, F., & Piva, S. (2025) · Veterinary Sciences · doi:10.3390/vetsci12050445 · Cited by 5
“…was defined in case of a decrease in the number of antibiotics used or the narrowing of the spectrum of antimicrobial treatment, while escalation was defined in the case of an increase in the number of antibiotics or the broadening of the spectrum, according to the definitions [11,12].”
Kadri, S. S., Warner, S., Rhee, C., Klompas, M., Follmann, D. A., Swihart, B., Laxminarayan, R., & Klein, E. Y. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad286 · Cited by 5
Epidemiology and Appropriateness of Antibiotic Prescribing in Severe Pneumonia After Lung Resection
Kernéis, S., Blanc, K., Caliez, J., Canouï, É., Loubinoux, J., Gauzit, R., Nguyen, Y.-L., Casetta, A., Lefebvre, A., Régnard, J., et al. (2019) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2019.01.072 · Cited by 5
A narrative review on antimicrobial therapy in septic shock: updates and controversies
Ling, L., Joynt, G. M., & Lipman, J. (2021) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000954 · Cited by 5
“The definition of deescalation is highly variable, however, in principle usually involves stepping down from broad-spectrum antibiotics to more narrow spectrum antimicrobials, stopping individual parts of a combination therapy, or shortening the duration of components of combination therapy [66].”
BackgroundSelf-citationPedroso, J. V. D. M., Motter, F. R., Koba, S. T., de Camargo, M. C., de Toledo, M. I., Fiol, F. D. S. D., Silva, M. T., & Lopes, L. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.576849 · Cited by 5
„Antibiotic Stewardship“: Maßnahmen zur Optimierung der Verordnung von Antiinfektiva
Lanckohr, C., & Bracht, H. (2018) · Der Anaesthesist · doi:10.1007/s00101-017-0398-x · Cited by 5
Modeling Antibiotic Use Strategies in Intensive Care Units: Comparing De-escalation and Continuation
Huo, X. (2019) · Bulletin of Mathematical Biology · doi:10.1007/s11538-019-00686-x · Cited by 5
Optimal and responsible use of antibiotics
Depuydt, P. O., & Waele, J. J. D. (2019) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000645 · Cited by 5
“This would imply that the antibiotic treatment is deescalated – both in terms of number of antibiotics aimed at the causative pathogens (as the use of double coverage antibiotic therapy is rarely indicated) as well as in terms of the spectrum in single agent antibiotic therapy [46].”
BackgroundAlame, D., Hess, B., & El‐Beyrouty, C. (2020) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2020.08.008 · Cited by 5
PNEUMONIA EM PACIENTES HOSPITALIZADOS POR TRAUMAS SOB TRATAMENTO INTENSIVO
Alves, J. N. B., Soares, L. G., Baratieri, T., Pitilin, É. D. B., Pelazza, B. B., Zanoti-Jeronymo, D. V., Caobianco, C. Z., & Lentsck, M. H. (2021) · Revista de Enfermagem UFPE on line · doi:10.5205/1981-8963.2021.245951 · Cited by 5
“escalonação ocorre quando é realizada a adição de um novo antimicrobiano ou a mudança para outro com cobertura de maior espectro.(25) Percebeu-se, segundo um estudo(26) que avaliou a importância do enfermeiro na execução do”
BackgroundAntimicrobial Agents in Agriculture and Their Implications in Antimicrobial Resistance
Singh, S., & Goyal, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-84126-3_3 · Cited by 5
Chakraverty, R., & Kundu, A. K. (2024) · Springer eBooks · doi:10.1007/978-981-96-0018-2_9 · Cited by 4
Kohama, Y., Kosugi, M., Arakawa, M., & Hidaka, S. (2022) · Die Pharmazie · doi:10.31083/ph.2022.2455 · Cited by 4
“For the purposes of this study, we defined de-escalation as a switch to a narrower-spectrum antimicrobial, a reduction in the number of antimicrobials used, or early discontinuation of antimicrobial treatment, as in previous research (Morel et al. 2010; Tabah et al. 2016).”
Alviset, S., Rodari, S., Poupet, H., Mizrahi, A., Gastli, N., Philippart, F., Charpentier, J., Pilmis, B., & Kernéis, S. (2023) · Infectious Diseases Now · doi:10.1016/j.idnow.2023.104773 · Cited by 4
Wilke, M. H., Heinlein, W., Stiefenhofer, L., & Bodmann, K. (2020) · GMS infectious diseases · doi:10.3205/id000069 · Cited by 4
“• AAT = adequate antimicrobial therapy • ASP = antimicrobial stewardship program • AST= antibiotic susceptibility test result • AT = antimicrobial therapy • BC = blood culture • BC+ = positive blood culture result • CFU = colony forming units • CM = contribution margin (in €) = revenue – costs of an individual patient…”
BackgroundInfluentialEvidence for the Application of Sepsis Bundles in 2021
Plata-Menchaca, E. P., Ruiz‐Rodríguez, J. C., & Ferrer, R. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1733899 · Cited by 4
In 2035, will all bacteria be multidrug-resistant? No
Barbier, F., Lipman, J., & Bonten, M. J. M. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4348-x · Cited by 4
Self-citationDaneman, N., Johnstone, J., Lee, T. C., MacFadden, D. R., McDonald, E. G., Morpeth, S. C., Ong, S. W. X., Paterson, D. L., Pinto, R. L., Rishu, A. H., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-101588 · Cited by 3
Mastrangelo, R. S., Hajizadeh, A., Piggott, T., Loeb, M. B., Wilson, M. G., Colunga‐Lozano, L. E., Roldán, Y., El-Khechen, H. A., Miroshnychenko, A., Thomas, P., et al. (2022) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2022/5630361 · Cited by 3
“Enablers, such as antimicrobial deescalation strategies, and rapid molecular testing coupled with communication interventions may be helpful in guiding appropriate use in hospitalized patients initially treated with broad-spectrum antibiotics (moderate quality of evidence) [79, 80].”
BackgroundTunçer, G., Geyiktepe-Güçlü, C., Sürme, S., Bayramlar, O. F., Çopur, B., Özdemir, Y. E., Güçlü, K. G., Pehlıvanoglu, F., Şengöz, G., & Yıldırım, M. (2023) · Revista médica de Chile · doi:10.4067/s0034-98872023001001319 · Cited by 3
“An appropriate empirical treatment was defined as treatment with an antibiotic according to susceptibility results within the first 48 hours after obtaining blood culture 23 .”
Escrihuela-Vidal, F., Palacios-Baena, Z. R., Agirre, J. G., Pérez-Rodríguez, M. T., Iglesias, J. M. R., Pedragosa, J. C., Gómez, L. S., Boix-Palop, L., Carrasco, A. B., Natera-Kindelán, C., et al. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107317 · Cited by 3
Kernéis, S., Leprince, C., Archambeau, D., Eyrolle, L. J., Leclerc, P., Poupet, H., Loubinoux, J., Gauzit, R., Salmon, D., Launay, O., et al. (2017) · Surgical Infections · doi:10.1089/sur.2017.106 · Cited by 3
Tamma, P. D., Miller, M. A., & Cosgrove, S. E. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202005-484ip · Cited by 3
Alghanem, A. F., AlDhahri, F., & Althemery, A. (2021) · Saudi Medical Journal · doi:10.15537/smj.2021.42.10.20210324 · Cited by 3
IN INTRA-ABDOMINAL INFECTIONS AND PERITONITIS
Kotov, A. V., Desyaterik, V. I., & Міхно, С. П. (2021) · Kharkiv Surgical School · doi:10.37699/2308-7005.2.2021.17 · Cited by 3
Microbiology Assessments in Critically Ill Patients
Brink, A. J., Centner, C. M., & Opperman, S. (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1741018 · Cited by 3
Recognizing the Unique Role of Critical Care Providers in Confronting Antimicrobial Resistance
Kadri, S. S. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201805-0962ed · Cited by 3
“Although the public health importance of antibiotic de-escalation is well known, its direct effect on ICU patients remains controversial (12).”
BackgroundElias, C., Rasoanandrasana, S., Raherinandrasana, A. H., Andriananja, V., Razanakolona, P. A., Randria, M. J. D. D., Raberahona, M., Raskine, L., Vanhems, P., & Babin, F.-X. (2025) · Journal of Hospital Infection · doi:10.1016/j.jhin.2025.09.025 · Cited by 2
Sepsis in Frail Older Adults: Tailored Antimicrobial Stewardship and Individualized Care Approach
Fabbri, E., Tebano, G., Angelis, A. D., Prete, A. D., Maestri, L., Cristini, F., & Muratori, P. (2026) · Antibiotics · doi:10.3390/antibiotics15050496 · Cited by 2
“A pillar of antimicrobial stewardship is de-escalation, which involves transitioning from a broad-spectrum antibiotic treatment to a more targeted one, based on the findings from antibiotic susceptibility tests [109–111].”
Singh, A., Ghosh, S., & Lyall, A. (2023) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24505 · Cited by 2
Actualités sur les durées de traitement et la désescalade antibiotique en infectiologie urinaire
Dinh, A., Bouchand, F., & Vallée, M. (2024) · Progrès en Urologie - FMC · doi:10.1016/j.fpurol.2024.03.005 · Cited by 2
ANTIBIOTICOTERAPIA COM INIBIDORES β-LACTÂMICOS PARA RESSENSIBILIZAÇÃO DE BACTÉRIAS MULTIRRESISTENTES
Barbosa, K. L., de Araújo, F. F., & Lins, D. F. S. (2020) · Infarma - Ciências Farmacêuticas · doi:10.14450/2318-9312.v32.e4.a2020.pp329-335 · Cited by 2
Antibiotic Stewardship in Community-acquired Pneumonia
van Heijl, I. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/332 · Cited by 2
Lee, G. R., & Kim, E. Y. (2022) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2022.09.096 · Cited by 1
A systematic review on de-escalation of antibiotics uses in surgical patients in clinical sepsis
sehrawat, H., Tantray, J., Kosey, S., HIMANSHI, H., Jwala, J., Khan, I. H., & Sohil (2023) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2023.18.1.0608 · Cited by 1
“(24,25,26) It is important to distinguish between empiric therapy and broad-spectrum therapy.”
BackgroundKebutuhan informasi pada keluarga pasien di intensive care unit: A scoping review
Supriyadi, Y., Kosasih, C. E., & Nuraeni, A. (2025) · HOLISTIK JURNAL KESEHATAN · doi:10.33024/hjk.v19i4.797 · Cited by 1
Lei, J., Zeng, L., Gao, X., Wang, D., & Li, H. (2025) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1177/10807683251366114 · Cited by 1
Song, Y., Li, C., Liu, X., & Gao, H. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70187 · Cited by 1
“Cholestatic injury, which constitutes approximately 30% of drug-induced liver injuries, is typically mild and manageable but can occasionally progress to vanishing bile duct syndrome [31, 32].”
Management of severe infections by multi-resistant Gram-negative bacteria in critically ill patients
Garnacho‐Montero, J., Adriaensens-Pérez, M., Aldabó-Pallás, T., Anaya-Carrión, N., Andaluz‐Ojeda, D., Cantón‐Bulnes, M. L., PASCALE, G. D., Fernández-Delgado, E., Póvoa, P. M. S. R., Galleymore, P. R., et al. (2026) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2026.502443 · Cited by 1
Self-citationNikolai, L. A., Hornuß, D., Gladstone, B. P., Walker, S. V., Vehreschild, J. J., Schmauder, K., Eisenbeis, S., Mischnik, A., Kramme, E., Geffers, C., et al. (2026) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2026.107908 · Cited by 1
Kitaura, S., Okamoto, K., Yamaguchi, R., Yamamoto, T., Tanaka, T., Kishida, T., Inoue, D., Miyashita, H., Ueda, M., Ikeuchi, K., et al. (2026) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2026.103033 · Cited by 1
Tsuzuki, S., Koizumi, R., Asai, Y., Hashimoto, Y., Inoue, N., & Ohmagari, N. (2026) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2026.107954 · Cited by 1
Antimicrobial stewardship program in critical care medicine: What is going on? Who gives more?
Zaragoza, R., & LLetí, A. C. C. (2017) · Medicina Intensiva · doi:10.1016/j.medin.2017.10.011 · Cited by 1
“Antimicrobial deescalation (ADE) of antimicrobial therapy, the cornerstone of ASP, is a strategy proposed to allow for the rational use of broad spectrum antimicrobial therapy as the empiric treatment for infections and minimize the overall exposure to these agents including the duration of the therapy.(1,2) However,…”
BackgroundMaltseva, L. А., Мосенцев, Н. Ф., & Lisnycha, V. M. (2018) · EMERGENCY MEDICINE · doi:10.22141/2224-0586.1.88.2018.124967 · Cited by 1
Ongoing Intraabdominal Infection Requiring ICU Care: Prioritizing Treatment Decisions
Weber, D. (2019) · Hot topics in acute care surgery and trauma · doi:10.1007/978-3-030-11830-3_15 · Cited by 1
Antimicrobial Stewardship in Intensive Care Unit
Ray, S. S. (2020) · Springer eBooks · doi:10.1007/978-981-15-4039-4_25 · Cited by 1
Measurement in Antibiotic Stewardship
Ashley, E. S. D., & Stenehjem, E. A. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316694411.008 · Cited by 1
How to use new antibiotics in the therapy of ventilator-associated pneumonia
Miwa, T., Lizza, B. D., Burnham, J. P., Honda, H., & Kollef, M. H. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000811 · Cited by 1
“The results of the RCTs may be affected by fewer numbers of patients actually infected by MDROs [86].”
BackgroundInfluentialHuo, X., & Liu, P. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301944 · Cited by 1
“And no significant difference has been observed between de-escalation and continuation on the individual patient outcomes, including length of ICU stay and mortality [8–12].”
Erazo-Rosero, M. S., Velásquez-Poveda, D. F., Cifuentes, J. R. P., Torres, J., Rosero, M. A. C., & Muñoz, B. A. M. (2025) · Arandu-UTIC. · doi:10.69639/arandu.v12i2.1136 · Cited by 1
Quelle définition et quelle stratification de la désescalade antibiotique ?
Zahar, J., Weiss, E., & Tabah, A. (2016) · Réanimation · doi:10.1007/s13546-015-1165-4 · Cited by 1
“Alors même que la politique de désescalade est largement utilisée et évaluée dans des travaux nationaux et internationaux, il n’existe aucune définition consensuelle et pratique dans la littérature permettant de guider le clinicien au lit du malade [3].”
BackgroundSelf-citationBacterial detection using an anharmonic acoustic aptasensor
Khobragade, S. (2018) · Loughborough University Institutional Repository (Loughborough University) · doi:10.26174/thesis.lboro.8132024.v1 · Cited by 1
Utility of blood cultures and patterns of antimicrobial resistance in dogs in Western Australia
Saarenkari, H. (n.d.) · Murdoch University Research Portal · Cited by 1
Antibiotic stewardship in the hospital setting
Chalmers, J. D., & Pletz, M. W. (2017) · European Respiratory Society eBooks · doi:10.1183/2312508x.10017616
Bus, L. D. (2018) · Ghent University Academic Bibliography (Ghent University)
Rodrigues, C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-27092018-095050
DiDiodato, G. (2018) · MacSphere (McMaster University) · doi:10.71548/24671
Évaluation fonctionnelle et structurale des HDL plasmatiques au cours des états inflammatoires
Tanaka, S. (2019) · theses.fr (ABES) · doi:10.70675/79cffc98zb83fz4b06z9a13zf694b711aafd
Antibiotic stewardship in critically ill patients with suspected ventilator-associated pneumonia
Yoshimura, J., Hashimoto, H., & Yamakawa, K. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-2421
“Recently, several systematic reviews showed that antimicrobial de-escalation reduced the use of broad-spectrum antibiotics without compromising patients’ outcomes in critically ill settings (3-5).”
BackgroundAntimicrobial stewardship in intensive care: identifying areas for improvement
Maher, D., Larcombe, R., Potts, S., & Wiersema, U. F. (2020) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1667
Li, Y., Yang, J., Yang, H., Guo, J., & Zhang, D. (2020) · doi:10.21203/rs.3.rs-106504/v1
Metadata
- Authors
- Tabah, A., Cotta, M. O., Garnacho-Montero, J., Schouten, J., Roberts, J. A., Lipman, J., Tacey, M., Timsit, J.-F., Leone, M., Zahar, J. R., & De Waele, J. J.
- Affiliations
- Royal Brisbane and Women's Hospital (AU)
- The University of Queensland (AU)
- Canisius-Wilhelmina Ziekenhuis (NL)
- Queensland University of Technology (AU)
- The Royal Melbourne Hospital (AU)
- Centre Hospitalier Universitaire d'Angers (FR)
- Corresponding author
- Tabah, Alexis
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-12-23
- Volume
- 62
- Issue
- 8
- Pages
- 1009-1017
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2253853790
- Cited by
- 220
- References
- 29
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 20 · 2023: 18 · 2022: 31 · 2021: 13 · 2020: 26 · 2019: 24 · 2018: 25 · 2017: 21 · 2016: 14 · 2015: 1
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- Clinical Infectious Diseases (publishedVersion, other-oa)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
- Funders
- Pfizer
- AstraZeneca
- Gilead Sciences
- Fonds Wetenschappelijk Onderzoek
- Astellas Pharma
- Vlaamse regering
- European Society of Intensive Care Medicine
- Medical Research Council
- National Health and Medical Research Council (1099452, 1048652)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antibiotic de-escalation, intensive care unit, antimicrobial resistance, mortality, broad-spectrum antimicrobial therapy, multidrug-resistant pathogens, severity scoring, clinical outcomes
- MeSH terms
- Anti-Bacterial Agents, Bacterial Infections, Clinical Trials as Topic, Cross Infection, Drug Resistance, Microbial, Humans, Intensive Care Units, Severity of Illness Index, Cohort Studies, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.